Activin, TGF-beta and Menin in Pituitary Tumorigenesis
Overview
General Medicine
Authors
Affiliations
Pituitary adenomas are common monoclonal neoplasms accounting for approximately one-fifth of primary intracranial tumors. Prolactin-secreting pituitary adenomas (prolactinomas) are the most common form of pituitary tumors in humans. They are associated with excessive release of the hormone prolactin and increased tumor growth, giving rise to severe endocrine disorders and serious clinical concerns for the patients. Recent studies indicated that the activin/TGF-beta family of growth factors plays a prominent role in regulating pituitary tumor growth and prolactin secretion from anterior pituitary lactotrope cells. Furthermore, these studies highlighted the tumor suppressor menin and the protein Smads as central regulators of these biological processes in the pituitary. Alterations in the activin/TGF-beta downstream signaling pathways are critical steps towards tumor formation and progression. This chapter will review the role and intracellular molecular mechanisms of action by which activin, TGF-beta, Smads and menin act in concert to prevent pituitary tumor cell growth and control hormonal synthesis by the anterior pituitary.
Boudreault J, Canaff L, Ghozlan M, Wang N, Guarnieri V, Salcuni A Cells. 2024; 13(11.
PMID: 38891107 PMC: 11172218. DOI: 10.3390/cells13110973.
Saksis R, Rogoza O, Niedra H, Megnis K, Mandrika I, Balcere I Cancer Cell Int. 2023; 23(1):25.
PMID: 36774501 PMC: 9922463. DOI: 10.1186/s12935-023-02863-4.
SFRP2 is a Novel Diagnostic Biomarker and Suppresses the Proliferation of Pituitary Adenoma.
Huang R, Chen D, Wang H, Zhang B, Zhang Y, Ren W J Oncol. 2022; 2022:4272525.
PMID: 36276274 PMC: 9586780. DOI: 10.1155/2022/4272525.
Hu J, Yin H, Li B, Yang H Diabetes Metab Syndr Obes. 2019; 12:2441-2451.
PMID: 31819570 PMC: 6885545. DOI: 10.2147/DMSO.S226056.
Darvasi O, Szabo P, Nemeth K, Szabo K, Spisak S, Liko I Pathol Oncol Res. 2017; 25(1):169-182.
PMID: 29043608 DOI: 10.1007/s12253-017-0330-3.